SCOPUS 정보 검색 플랫폼

Journal of Clinical Oncology

Volumn 27, Issue 18, 2009, Pages 2898-2899

Is there a standard of care for pathologic stage T3 prostate cancer?

(3) Thompson, Ian M a Tangen, Catherine M b Klein, Eric A c

a Mays Cancer Center at UT Health San Antonio (United States)

b Fred Hutchinson Cancer Research Center (United States)

c LERNER RESEARCH INSTITUTE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

CANCER GROWTH; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL DECISION MAKING; EDITORIAL; FOLLOW UP; GLEASON SCORE; HIGH RISK PATIENT; HUMAN; METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE CANCER; STANDARDIZATION; SURGICAL APPROACH; SURVIVAL RATE; TREATMENT OUTCOME; ADJUVANT THERAPY; MALE; NOTE; PROSTATE TUMOR; RANDOMIZED CONTROLLED TRIAL;

HUMANS; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 67649921336 PISSN: 0732183X EISSN: None Source Type: Journal
DOI: 10.1200/JCO.2008.20.9460 Document Type: Editorial

Times cited : (31)

References (5)

1
- 1642282734
- The contemporary management of prostate cancer in the United States: Lessons from the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE), a national disease registry
- Cooperberg MR, Broering JM, Litwin MS, et al: The contemporary management of prostate cancer in the United States: Lessons from the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE), a national disease registry. J Urol 171:1393-1401, 2004
- (2004) J Urol , vol.171 , pp. 1393-1401
- Cooperberg, M.R.¹ Broering, J.M.² Litwin, M.S.³

2
- 33751018522
- Adjuvant radiotherapy for pathologically advanced prostate cancer: A randomized clinical trial
- Thompson IM, Tangen CM, Paradelo J, et al: Adjuvant radiotherapy for pathologically advanced prostate cancer: A randomized clinical trial. JAMA 296:2329-2335, 2006
- (2006) JAMA , vol.296 , pp. 2329-2335
- Thompson, I.M.¹ Tangen, C.M.² Paradelo, J.³

3
- 23744493443
- Postoperative radiotherapy after radical prostatectomy: A randomised controlled trial (EORTC trial 22911)
- Bolla M, van Poppel H, Collette L, et al: Postoperative radiotherapy after radical prostatectomy: A randomised controlled trial (EORTC trial 22911). Lancet 366:572-578, 2005
- (2005) Lancet , vol.366 , pp. 572-578
- Bolla, M.¹ van Poppel, H.² Collette, L.³

4
- 67649992725
- Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95
- Wiegel T, Bottke D, Steiner U, et al: Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. J Clin Oncol 27:2924-2930, 2009
- (2009) J Clin Oncol , vol.27 , pp. 2924-2930
- Wiegel, T.¹ Bottke, D.² Steiner, U.³

5
- 59549095954
- Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: Long-term followup of a randomized clinical trial
- Thompson IM, Tangen CM, Paradelo J, et al: Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: Long-term followup of a randomized clinical trial. J Urol 181:956-962, 2009
- (2009) J Urol , vol.181 , pp. 956-962
- Thompson, I.M.¹ Tangen, C.M.² Paradelo, J.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.